Pfizer Inc To Acquire Arena Pharmaceuticals Inc - M&A Call Transcript
Good day, everyone, and welcome to Pfizer's analyst and investor call to discuss the proposed acquisition of Arena Pharmaceuticals, Inc. Today's call is being recorded.
At this time, I would like to turn the call over to Mr. Chris Stevo, Senior Vice President and Chief Investor Relations Officer. Please go ahead, sir.
Thank you, Sylvia. Good morning, everyone, and thank you for joining us on short notice. We'll be making forward-looking commentary and statements during the call regarding, amongst other topics, our I&I pipeline, in-line products and product candidates and the proposed acquisition of Arena Pharmaceuticals, Inc. by Pfizer, which are subject to risks and uncertainties.
Additional information regarding forward-looking statements is available under Risk Factors and forward-looking information and factors that may affect future results in our SEC filings on Form 10-K and 10-Q and in the press release we issued this morning. Forward-looking statements on the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |